STAT Plus: Biotech earnings preview: Unsettled investors hoping for strong 2020 outlooks
ADOBE
This week should be meaningful, with four major biopharma companies providing investors with their financial outlooks for 2020.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario